Citius Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CTXR Nasdaq 2834 citiuspharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Citius Pharmaceuticals, Inc.

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025 - Jun 17th, 2025 6:08 am
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - Jun 12th, 2025 6:35 am
Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - Jun 10th, 2025 5:00 am
Citius Oncology Enters into Distribution Services Agreement with Cardinal Health - Jun 9th, 2025 6:37 am
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update - May 14th, 2025 2:30 pm
Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - May 5th, 2025 6:37 am
Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock - Apr 1st, 2025 7:00 am
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services - Feb 6th, 2025 6:55 am
Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - Jan 8th, 2025 6:00 am
Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025 - Jan 7th, 2025 6:08 am
Citius Oncology to explore strategic alternatives - Jan 7th, 2025 5:57 am
Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives - Jan 6th, 2025 5:50 am
Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital - Dec 31st, 2024 5:10 am
American Air upgraded, Nordstrom downgraded: Wall Street's top analyst calls - Dec 30th, 2024 7:43 am
Citius Pharma Reports 2024 Financial Results and Business Update - Dec 29th, 2024 8:50 pm
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update - Dec 27th, 2024 3:00 pm
Market Sentiment Around Loss-Making Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Dec 27th, 2024 7:23 am
Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval - Nov 25th, 2024 6:03 am
Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split - Nov 22nd, 2024 7:00 am
Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering - Nov 18th, 2024 2:05 pm